544
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Thermosensitive liposomal cisplatin in combination with local hyperthermia results in tumor growth delay and changes in tumor microenvironment in xenograft models of lung carcinoma*

ORCID Icon, , , , , & show all
Pages 865-877 | Received 02 Mar 2016, Accepted 15 May 2016, Published online: 16 Jun 2016

References

  • American Cancer Society . Lung Cancer (Non-Small Cell). Available from: http://www.cancer.org/acs/groups/cid/documents/webcontent/003115-pdf.pdf [last accessed Jan 2016].
  • D’Addario G , Pintilie M , Leighl NB , et al . Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature. J Clin Oncol 2005;23:2926–36.
  • Belani C , Ramalingam S. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. Oncologist 2008;13:5–13.
  • Reck M , Heigener DF , Mok T , et al . Management of non-small-cell lung cancer: recent developments. Lancet 2013;382:709–19.
  • Ardizzoni A , Tiseo M , Boni L , et al . Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst 2007;99:847–57.
  • Boulikas T , Vougiouka M. Cisplatin and platinum drugs at the molecular level (review). Oncol Rep 2003;10:1663–82.
  • NCI NIH Website, Adult Primary Liver Cancer Treatment (PDQ®)–Health Professional Version. Available from: http://www.cancer.gov/about-cancer/treatment/drugs/lung [last accessed Jan 2015].
  • Alberts DS , Noel JK. Cisplatin-associated neurotoxicity: can it be prevented? Anticancer Drugs 1995;6:369–83.
  • Storm G , Lammers T , Hennink WE. Tumour-targeted nanomedicines: principles and practice. Br J Cancer 2008;99:392–7.
  • Mylonakis N , Athanasiou A , Ziras N , et al . Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer. Lung Cancer 2010;68:240–7.
  • White SC , Lorigan P , Margison GP , et al . Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer. Br J Cancer 2006;95:822–8.
  • Boulikas T , Stathopoulos GP , Volakakis N , Vougiouka M. Systemic lipoplatin infusion results in preferential tumor uptake in human studies. Anticancer Res 2005;25:3031–9.
  • Kim ES , Lu C , Khuri FR , et al . A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer. Lung Cancer 2001;34:427–32.
  • Terwogt JMM , Groenewegen G , Pluim D , et al . Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin. Cancer Chemoth Pharm 2002;49:201–10.
  • Ravaioli A , Papi M , Pasquini E , et al . Lipoplatin monotherapy: a phase II trial of second-line treatment of metastatic non-small-cell lung cancer. J Chemotherapy 2009;21:86–90.
  • Stathopoulos GP , Antoniou D , Dimitroulis J , et al . Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial. Ann Oncol 2010;21:2227–32.
  • Dou YN , Zheng J , Foltz WD , et al . Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice. J Control Release 2014;178:69–78.
  • Ahmed F , Steele JC , Herbert JMJ , et al . Tumor stroma as a target in cancer. Curr Cancer Drug Targets 2008;8:447–53.
  • Hanahan D , Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646–74.
  • Hildebrandt B , Wust P , Ahlers O , et al . The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002;43:33–56.
  • Vaupel PW , Kelleher DK. Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: heterogeneity is the key issue. Int J Hyperthermia 2010;26:211–23.
  • Dudar TE , Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res 1984;44:605–12.
  • Vujaskovic Z , Poulson JM , Gaskin AA , et al . Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment. Int J Radiat Oncol Biol Phys 2000;46:179–85.
  • Pang CLK. Physical technology and biological basis of hyperthermia in oncology. In: Hyperthermia in oncology. Boca Raton (FL): CRC Press; 2015.
  • Charles River Website. Available from: http://www.criver.com/files/pdfs/rms/eu/immunodeficient-mice-eu.aspx [last accessed Feb 2016].
  • Shen WC and Louie SG Immunology for pharmacy Students. Amsterdam, The Netherlands: Harwood Academic; 2005.
  • Tizard IR. The defense of the body. In: Veterinary immunology. St. Louis (MO): Saunders; 2013. 1–10.
  • Dou YN , Weersink RA , Foltz WD , et al . Custom-designed laser-based heating apparatus for triggered release of cisplatin from thermosensitive liposomes with magnetic resonance image guidance. J Vis Exp 2015; 106:e53055.
  • Goodwin CJ , Holt SJ , Downes S , Marshall NJ . Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS. J Immunol Methods 1995;179:95–103.
  • National Cancer Institute Developmental Therapeutics Program: cell Lines in the In Vitro Screen. Available from: https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm [last accessed Jan 2015].
  • American Cancer Society. Lung Cancer (Non-Small Cell). Available from: http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-what-is-non-small-cell-lung-cancer [last accessed Feb 2016].
  • Lepock JR. Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage. Int J Hyperthermia 2003;19:252–66.
  • Weiswald LB , Bellet D , Dangles-Marie V. Spherical cancer models in tumor biology. Neoplasia 2015;17:1–15.
  • Baker BM , Chen CS . Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci 2012;125:3015–24.
  • Huang SK , Stauffer PR , Hong K , et al . Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res 1994;54:2186–91.
  • Cope DA , Dewhirst MW , Friedman HS , et al . Enhanced delivery of a monoclonal antibody F(ab’)2 fragment to subcutaneous human glioma xenografts using local hyperthermia. Cancer Res 1990;50:1803–9.
  • Zhu D , Lu W , Weng Y , et al . Monitoring thermal-induced changes in tumor blood flow and microvessels with laser speckle contrast imaging. Appl Opt 2007;46:1911–7.
  • Song CW , Shakil A , Osborn JL , Iwata K. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperther 2009;25:91–5.
  • Rappaport DS , Song CW. Blood flow and intravascular volume of mammary adenocarcinoma 13726A and normal tissues of rat during and following hyperthermia. Int J Radiat Oncol Biol Phys 1983;9:539–47.
  • Song CW , Rhee JG , Levitt SH. Blood flow in normal tissues and tumors during hyperthermia. J Natl Cancer Inst 1980;64:119–24.
  • Song CW , Kang MS , Rhee JG , Levitt SH. Effect of hyperthermia on vascular function in normal and neoplastic tissues. Ann N Y Acad Sci 1980;335:35–47.
  • Dickson JA , Calderwood SK. Temperature range and selective sensitivity of tumors to hyperthermia: a critical review. Ann N Y Acad Sci 1980;335:180–205.
  • van Bree C , Krooshoop JJ , Rietbroek RC , et al . Hyperthermia enhances tumor uptake and antitumor efficacy of thermostable liposomal daunorubicin in a rat solid tumor. Cancer Res 1996;56:563–8.
  • Kong G , Braun RD , Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res 2000;60:4440–5.
  • Kong G , Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999;15:345–70.
  • Ning S , Macleod K , Abra RM , et al . Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. Int J Radiat Oncol Biol Phys 1994;29:827–34.
  • de Smet M , Langereis S , van den Bosch S , et al . SPECT/CT imaging of temperature-sensitive liposomes for MR-image guided drug delivery with high intensity focused ultrasound. J Control Release 2013;169:82–90.
  • Manzoor AA , Lindner LH , Landon CD , et al . Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res 2012;72:5566–75.
  • de Smet M , Hijnen NM , Langereis S , et al . Magnetic resonance guided high-intensity focused ultrasound mediated hyperthermia improves the intratumoral distribution of temperature-sensitive liposomal doxorubicin. Invest Radiol 2013;48:395–405.
  • Reinhold HS , Vandenbergblok A . Enhancement of thermal damage to the microcirculation of 'sandwich' tumours by additional treatment. Eur J Cancer Clin Oncol 1981;17:781–95.
  • Song CW. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res 1984;44:4721s–30s.
  • Kelleher DK , Vaupel P. Vascular effects of localized hyperthermia. In: Hyperthermia in cancer treatment: a primer. Landes Bioscience: Georgetown; 2008.
  • Tozer GM , Kanthou C , Baguley BC. Disrupting tumour blood vessels. Nat Rev Cancer 2005;5:423–35.
  • Paku S , Paweletz N. First steps of tumor-related angiogenesis. Lab Invest 1991;65:334–46.
  • Baluk P , Morikawa S , Haskell A , et al . Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 2003;163:1801–15.
  • Jain RK , Wardhartley K. Tumor blood-flow - characterization, modifications, and role in hyperthermia. LEEE T Son Ultrason 1984;31:504–26.
  • Hauck ML , Dewhirst MW , Zalutsky MR. Enhancement of radiolabeled monoclonal antibody uptake in tumors with local hyperthermia. In: Torchilin VP, ed. Handbook of targeted delivery of imaging agents. Boca Raton (FL): CRC Press; 1995.
  • Frohlich D , Wittmann S , Rothe G , et al. Mild hyperthermia down-regulates receptor-dependent neutrophil function. Anesth Analg 2004;99:284–92.
  • Anderson DC. The role of β2 integrins and intercellular adhesion molecule type 1 in inflammation. In: Granger DN , Schmid-Schonbein GW , eds. Physiology and pathophysiology of leukocyte adhesion. Oxford, England: Oxford University Press; 1995.
  • Waite, G.N. Immunology, organ interaction, and homeostasis. In: Rhoades RA , Bell DR , eds. Medical physiology: principles for clinical medicine. Philadelphia (PA): Lippincott Williams & Wilkins; 2013.
  • Kubes J , Svoboda J , Rosina J , et al . Immunological response in the mouse melanoma model after local hyperthermia. Physiol Res 2008;57:459–65.
  • Kuo LJ , Yang LX. gamma-H2AX - a novel biomarker for DNA double-strand breaks. In Vivo 2008;22:305–9.
  • Cook PJ , Ju BG , Telese F , et al . Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 2009;458:591–6.
  • Wang J , Jia Y , Wang N , et al . The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma. J Transl Med 2014;12:7.
  • Pillay J , den Braber I , Vrisekoop N , et al . In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood 2010;116:625–7.
  • Kolaczkowska E , Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013;13:159–75.
  • Galli SJ , Borregaard N , Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 2011;12:1035–44.
  • Zhang Y , Wallace DL , de Lara CM , et al . In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 2007;121:258–65.
  • Fox S , Leitch AE , Duffin R , et al . Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease. J Innate Immun 2010;2:216–27.
  • Henson PM. Dampening inflammation. Nat Immunol 2005;6:1179–81.
  • Moroi J , Kashiwagi S , Kim S , et al . Regional differences in apoptosis in murine gliosarcoma (T9) induced by mild hyperthermia. Int J Hyperthermia 1996;12:345–54.
  • Vakkila J , Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol 2004;4:641–8.
  • Scaffidi P , Misteli T , Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191–5.
  • Parker KH , Sinha P , Hom LA , et al . HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells. Cancer Res 2014;74:5723–33.
  • Gabrilovich DI , Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162–74.
  • Balkwill FR , Capasso M , Hagemann T. The tumor microenvironment at a glance. J Cell Sci 2012;125:5591–6.
  • Nishimura Y , Okuno Y , Horii N , et al . Microangiographic and histologic analysis of the effects of hyperthermia on murine tumor vasculature. Int J Radiat Oncol Biol Phys 1988;15:411–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.